We present the case of a patient with chronic autoimmune atrophic gastritis (CAAG) with non-acidic gastroesophageal reflux disease (GERD) demonstrated with 24-hour multichannel intraluminal impedance-pH (MII-pH) monitoring who was successfully treated with laparoscopic antireflux surgery. Written and oral informed consent was obtained from the patient for the communication of this case.
and symptomatic index were positive (> 95% and > 50% respectively) for all 3 symptoms.
The patient was offered surgery, which she accepted, and underwent laparoscopic Nissen fundoplication with associated hiatal repair. She experienced great improvement, with remission of all symptoms (regurgitation, cough, dysphagia, and belching). Postsurgical manometry and MII-pH monitoring revealed objective improvement: lower esophageal sphincter mean resting pressure of 11 mmHg, 79 non-acidic refluxes, and bolus exposure time of 1.2%.
This case report represents, to our knowledge, the first communication of a patient with objectively proven GERD due to nonacidic reflux in the context of CAAG who was satisfactorily treated with fundoplication, with improvement in symptoms and in objective parameters. Old reports described patients with achlorhydria with esophagitis that was attributed hypothetically to biliary reflux, but with no objective demonstration. 1 More recent studies showed the utility of MII-pH monitoring in demonstrating symptomatic refluxes in patients with CAAG, but they reported no treatment outcome other than improvement with sucralfate in one case. 2, 3 In spite of hypo-or achlorhydria, patients with CAAG do still have gastroesophageal reflux, mostly non-acidic, and if it causes symptoms it will be constitutive of a proper GERD. MII-pH monitoring is the test of choice in this setting due to its capacity of detecting any type of reflux. Patients so diagnosed would be candidates to GERD treatments such as baclofen or anti-reflux surgery, as are proton pump inhibitor-refractory conventional GERD patients whose symptoms are due to persistent refluxes as demonstrated as well with MII-pH monitoring done on-therapy with proton pump inhibitor. 4, 5 
